Specialists from the Digestive System Department at Hospital Germans Trias have conducted and published a unique study that ...
It is normal for two illnesses symptoms to overlap but if both have been correctly diagnosed choosing a course of therapy is ...
Mobileum Inc. (“Mobileum”), a leading global provider of analytics and network solutions, is thrilled to announce the release of RAID 9, the latest evolution of its industry-leading risk management ...
Triastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive results in recent clinical study. D23 is budesonide ...
Triastek advances 3D printed drug D23 - a delayed-release budesonide tablet produced using Triastek’s proprietary MED - for ...
Chen, D. and Li, L. (2025) Huge Pelvic GIST Got Good Control after Resistance to Tyrosine Kinase Inhibitors by SIB-IMRT: A ...
Triastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive results in recent clinical study. D23 is budesonide ...
NANJING, China--(BUSINESS WIRE)--Triastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive results in recent ...
NANJING, China--(BUSINESS WIRE)--#3DPrintingPharmaceutical--Triastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results